112 related articles for article (PubMed ID: 18066112)
21. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor.
Zhang Y; Guo X; Lin ET; Benet LZ
Drug Metab Dispos; 1998 Apr; 26(4):360-6. PubMed ID: 9531525
[TBL] [Abstract][Full Text] [Related]
22. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects on cytochrome p450 enzymes of pentamidine and its amidoxime pro-drug.
Bürenheide A; Kunze T; Clement B
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):61-5. PubMed ID: 18346045
[TBL] [Abstract][Full Text] [Related]
25. Effect of extracts of Orthosiphon stamineus Benth, Hieracium pilosella L., Sambucus nigra L. and Arctostaphylos uva-ursi (L.) Spreng. in rats.
Beaux D; Fleurentin J; Mortier F
Phytother Res; 1999 May; 13(3):222-5. PubMed ID: 10353162
[TBL] [Abstract][Full Text] [Related]
26. Risk assessment of free hydroquinone derived from Arctostaphylos Uva-ursi folium herbal preparations.
de Arriba SG; Naser B; Nolte KU
Int J Toxicol; 2013; 32(6):442-53. PubMed ID: 24296864
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of hop-containing products on human cytochrome p450-mediated metabolism.
Foster BC; Kearns N; Arnason JT; Saleem A; Ogrodowczyk C; Desjardins S
J Agric Food Chem; 2009 Jun; 57(11):5100-5. PubMed ID: 19489632
[TBL] [Abstract][Full Text] [Related]
28. A single extraction step in the quantitative analysis of arbutin in bearberry (Arctostaphylos uva-ursi) leaves by high-performance liquid chromatography.
Parejo I; Viladomat F; Bastida J; Codina C
Phytochem Anal; 2001; 12(5):336-9. PubMed ID: 11705262
[TBL] [Abstract][Full Text] [Related]
29. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
[TBL] [Abstract][Full Text] [Related]
30. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
Akutsu T; Kobayashi K; Sakurada K; Ikegaya H; Furihata T; Chiba K
Drug Metab Dispos; 2007 Jan; 35(1):72-8. PubMed ID: 17020955
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human cytochrome p450 metabolism by blended herbal products and vitamins.
Tam TW; Akhtar H; Arnason JT; Cvijovic K; Boon H; Cameron DW; Drouin CE; Jaeger W; Tsuyuki RT; Vohra S; Foster BC
J Pharm Pharm Sci; 2011; 14(1):1-16. PubMed ID: 21501549
[TBL] [Abstract][Full Text] [Related]
32. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
33. Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells.
Hansen TS; Nilsen OG
Phytother Res; 2009 Jan; 23(1):86-91. PubMed ID: 18688789
[TBL] [Abstract][Full Text] [Related]
34. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4.
Lefebvre T; Foster BC; Drouin CE; Krantis A; Livesey JF; Jordan SA
J Pharm Pharm Sci; 2004 Aug; 7(2):265-73. PubMed ID: 15367385
[TBL] [Abstract][Full Text] [Related]
37. Chemical Characteristics and Antioxidant Activity of
Sugier P; Sęczyk Ł; Sugier D; Krawczyk R; Wójcik M; Czarnecka J; Okoń S; Plak A
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946773
[TBL] [Abstract][Full Text] [Related]
38. Bearberry identification by a multidisciplinary study on commercial raw materials.
Gallo FR; Multari G; Pagliuca G; Panusa A; Palazzino G; Giambenedetti M; Petitto V; Nicoletti M
Nat Prod Res; 2013 Apr; 27(8):735-42. PubMed ID: 22712621
[TBL] [Abstract][Full Text] [Related]
39. Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial.
Moore M; Trill J; Simpson C; Webley F; Radford M; Stanton L; Maishman T; Galanopoulou A; Flower A; Eyles C; Willcox M; Hay AD; van der Werf E; Gibbons S; Lewith G; Little P; Griffiths G
Clin Microbiol Infect; 2019 Aug; 25(8):973-980. PubMed ID: 30685500
[TBL] [Abstract][Full Text] [Related]
40. Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its Alkaloids.
Manda VK; Ibrahim MA; Dale OR; Kumarihamy M; Cutler SJ; Khan IA; Walker LA; Muhammad I; Khan SI
Planta Med; 2016 Apr; 82(6):551-8. PubMed ID: 27054913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
